Zobrazeno 1 - 10
of 82
pro vyhledávání: '"Carsten-Henning Ohlmann"'
Autor:
Carsten-Henning Ohlmann, Matthias Saar, Laura-Christin Pierchalla, Miran Zangana, Alena Bonaventura, Michael Stöckle, Stefan Siemer, Julia Heinzelbecker
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract Data on robotic retroperitoneal lymph node dissection (R-RPLND) for metastatic testicular germ cell tumours (mTGCTs) are scarce and the use of R-RPLND itself is still under debate. The aim of our study was to evaluate the indications, feasib
Externí odkaz:
https://doaj.org/article/b18e3de261a34a17aa53ba400e94d3e5
Autor:
Yuri Tolkach, Anika Kremer, Gábor Lotz, Matthias Schmid, Thomas Mayr, Sarah Förster, Stephan Garbe, Sana Hosni, Marcus V. Cronauer, Ildikó Kocsmár, Éva Kocsmár, Péter Riesz, Abdullah Alajati, Manuel Ritter, Jörg Ellinger, Carsten-Henning Ohlmann, Glen Kristiansen
Publikováno v:
Cancers, Vol 14, Iss 18, p 4441 (2022)
Background: Canonical androgen receptor (AR) signaling regulates a network of DNA repair genes in prostate cancer (PCA). Experimental and clinical evidence indicates that androgen deprivation not only suppresses DNA repair activity but is often synth
Externí odkaz:
https://doaj.org/article/f3788f3052ca47f5b5a5d6a7f647d9bb
Autor:
Martin W. W. Janssen, Johannes Linxweiler, Ines Philipps, Zentia Bütow, Stefan Siemer, Michael Stöckle, Carsten-Henning Ohlmann
Publikováno v:
World Journal of Surgical Oncology, Vol 16, Iss 1, Pp 1-6 (2018)
Abstract Background Kidney autotransplantation (KAT) is the ultimate approach for nephron-sparing surgery. It is a rarely used method in renal tumor surgery today as minimal invasive and open techniques for nephron-sparing surgery improve constantly.
Externí odkaz:
https://doaj.org/article/69219f567c234b4e8a646959eefc57ea
Autor:
Carsten-Henning Ohlmann, Michelle Jäschke, Peter Jaehnig, Susane Krege, Jürgen Gschwend, Heidrun Rexer, Michael Stöckle
Publikováno v:
Trials, Vol 18, Iss 1, Pp 1-9 (2017)
Abstract Background The value of continuation of luteinizing hormone-releasing hormone (LHRH) therapy in castration-resistant prostate cancer (CRPC) remains controversial and clear evidence is lacking. Argumentation for cessation of LHRH therapy is t
Externí odkaz:
https://doaj.org/article/690cf09f4623408381878b95f241dadc
Publikováno v:
Aktuelle Urologie. 53:159-166
ZusammenfassungDie radikale Zystektomie (RC) mit Anlage einer Harnableitung (HA) ist ein umfangreicher und anspruchsvoller abdomineller Eingriff. Es bestehen durch die Operation selbst sowie aufgrund patientenindividueller Komorbiditäten erhebliche
Autor:
Heidrun Rexer, Carsten-Henning Ohlmann
Publikováno v:
Uro-News. 27:50-51
Autor:
Carsten-Henning Ohlmann
Publikováno v:
Prostate Cancer and Prostatic Diseases.
Autor:
Michael Stöckle, Martin Janssen, Ines Philipps, Stefan Siemer, Carsten-Henning Ohlmann, Zentia Bütow, Johannes Linxweiler
Publikováno v:
World Journal of Surgical Oncology
World Journal of Surgical Oncology, Vol 16, Iss 1, Pp 1-6 (2018)
World Journal of Surgical Oncology, Vol 16, Iss 1, Pp 1-6 (2018)
Background Kidney autotransplantation (KAT) is the ultimate approach for nephron-sparing surgery. It is a rarely used method in renal tumor surgery today as minimal invasive and open techniques for nephron-sparing surgery improve constantly. In this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::696c07c212b18314289b282d8e001530
Autor:
Philipp Krausewitz, Ralph Alexander Bundschuh, Florian C. Gaertner, Markus Essler, Ulrike Attenberger, Julian Luetkens, Glen Kristiansen, Michael Muders, Carsten-Henning Ohlmann, Stefan Hauser, Jörg Ellinger, Manuel Ritter
Background: Primary objective: To determine the proportion of men with suspected prostate cancer (PCA) in whom the management plans are changed by additive Gallium-68 prostate-specific membrane antigen positron emission tomography/computed tomography
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::35d71997558d0a786a622dc3a683a15d
https://doi.org/10.21203/rs.3.rs-2155499/v1
https://doi.org/10.21203/rs.3.rs-2155499/v1
Autor:
Carsten-Henning Ohlmann, Michelle Jäschke, Peter Jaehnig, Susanne Krege, Jürgen Gschwend, Heidrun Rexer, Kerstin Junker, Roger Zillmann, Christoph Rüssel, Eva Hellmis, Henrik Suttmann, Martin Janssen, Jan Marin, Andreas Hübner, Michael Mathers, Jochen Gleißner, Michael Scheffler, Susan Feyerabend, Jens Telle, Jörg Klier, Michael Stöckle
Background Although the benefit of androgen deprivation therapy (ADT) continuation in metastatic castration-resistant prostate cancer (mCRPC) remains controversial, clinical evidence is lacking. Recent results indicated that treatment with abirateron
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8e19dd991763bf7d9060ca36a498e3b